ATP Life Science Ventures, L.P.'s Net Worth
-$66.4 Million
Who is ATP Life Science Ventures, L.P.?
ATP Life Science Ventures, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TITAN PHARMACEUTICALS INC, Stoke Therapeutics, Inc., Akero Therapeutics, Inc., Tokai Pharmaceuticals Inc, and Cerecor Inc..
SEC CIK
ATP Life Science Ventures, L.P.'s CIK is 0001593440
Past Insider Trading and Trends
2019 was ATP Life Science Ventures, L.P.'s most active year for acquiring shares with 7 total transactions. ATP Life Science Ventures, L.P.'s most active month to acquire stocks was the month of May. 2019 was ATP Life Science Ventures, L.P.'s most active year for disposing of shares, totalling 5 transactions. ATP Life Science Ventures, L.P.'s most active month to dispose stocks was the month of May. 2019 saw ATP Life Science Ventures, L.P. paying a total of $39,400,002.00 for 22,201,916 shares, this is the most they've acquired in one year. In 2021 ATP Life Science Ventures, L.P. cashed out on 22,991,916 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.83M |
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +7.66% | 415K |
$36.00 | $14,940,000.00 | 5.83M |
Jul 10
| |||
Form 4
|
∞
| 5.42M |
$16.00 |
—
| 5.42M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TITAN PHARMACEUTICALS INC (TTNP) Snapshot price: $6.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerecor Inc. (AVTX) Snapshot price: $4.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 595.44K |
—
|
—
| 595.44K |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Stoke Therapeutics, Inc. (STOK) Snapshot price: $4.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.16M |
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +2.23% | 375K |
$39.00 | $14,625,000.00 | 17.16M |
Nov 24
| |||
Form 4
|
∞
| 16.79M |
$18.00 | $25,000,002.00 | 16.79M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tokai Pharmaceuticals Inc (ELDN) Snapshot price: $1.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||